Propiedad y actividad de insiders de Jasper Therapeutics, Inc. (JSPR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.58 |
| Capitalización | $9M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-31 | WIGGANS THOMAS G | A-Award | 7,500 | $5K |
| 2026-07-31 | Lucas Svetlana | A-Award | 7,500 | $5K |
| 2026-07-31 | Crutcher Patrick J | A-Award | 7,500 | $5K |
| 2026-07-31 | EMSTER KURT VON | A-Award | 7,500 | $5K |
| 2026-07-31 | Shizuru Judith Anne | A-Award | 7,500 | $5K |
| 2026-07-16 | Keenan Greg | 103,204 | $1K | |
| 2026-07-16 | Keenan Greg | 92,278 | $56K | |
| 2026-07-20 | Ros Matthew E | P-Purchase | 881 | |
| 2026-07-16 | Song Wenru | |||
| 2026-07-16 | Song Wenru |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $27.2M | $19.8M | $84.7M | $38.2M | $86.9M | $71.6M | $28.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $600000 | 0 | 0 | $250000 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $27.2M | $20.7M | $87.8M | $41.7M | $88.9M | $75.8M | $34.6M |
| Inmovilizado Material | 0 | $2.0M | $4.8M | $5.5M | $4.2M | $2.9M | $604000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $27.2M | $23.4M | $93.7M | $48.4M | $94.9M | $79.9M | $35.8M |
| Cuentas por Pagar | $623000 | $1.4M | $3.9M | $1.8M | $4.1M | $4.0M | $6.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.0M | $4.0M | $8.0M | $7.1M | $12.4M | $15.2M | $13.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $6.1M | $58.5M | $24.1M | $12.4M | $16.5M | $18.2M | $31.6M |
| Reservas | -$5.1M | -$36.8M | -$67.5M | -$105.1M | -$169.6M | -$240.9M | -$316.7M |
| Patrimonio Neto | $21.1M | -$35.1M | $69.5M | $36.0M | $78.4M | $61.7M | $4.2M |
| Deuda Total | 0 | $1.6M | $2.9M | $3.7M | $2.8M | $1.8M | $1.2M |
| Deuda Neta | -$27.2M | -$18.2M | -$81.8M | -$34.6M | -$84.1M | -$69.8M | -$27.5M |
| Capital Circulante | $25.2M | $16.7M | $79.8M | $34.7M | $76.6M | $60.6M | $21.4M |
Salud financiera
| Deuda / Patrimonio | 0.19 |
| Ratio corriente | 1.47 |
| Piotroski F-Score | 0 |
| Altman Z-Score | -18.43 |
Rentabilidad
| Rentabilidad sobre capital | -618.87% |
| Rentabilidad sobre capital invertido | -1305.04% |
| Rentabilidad sobre activos | -269.20% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: BOLD · BTAI · CELU · GBIO · MURA · NXTC · PSTV
Explorar sector: Healthcare · Biotechnology
Más secciones de JSPR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones